On Oct. 1, UnitedHealthcare’s national prior authorization gold-card program went into effect. The payer announced the program in August and rolled out its list of eligible procedures on Sept. 1, which included several ASC-related codes.
Researchers from UCLA Health’s Jonsson Comprehensive Cancer Center received a $3 million grant from the National Institutes of Health to enhance follow-up care after colorectal cancer screenings in underserved populations.
A new study, published in the Journal of Robotic Surgery, shows that robotic surgery provides an advantage for patients over traditional laparoscopic approaches to colorectal resections.
RedHill Biopharma, a specialty biopharmaceutical company with a focus on developing treatments for the bacterial infection H. pylori, has renewed its contract with Medi-Cal, California’s Medicaid healthcare program.
The former CEO of a hospital in Rockdale, Texas, has agreed to pay more than $5.3 million to resolve allegations of paying kickbacks to physicians for laboratory referrals.
Here are five major transactions in the third quarter significantly reshaping the ASC industry, reflecting broader trends in consolidation and strategic partnerships.
Independent physicians and ASC operators are closely monitoring the ongoing wave of hospital sales and market consolidation, amid the potential for reduced competition, rising costs and limited referral networks.
San Diego-based lab company Precision Toxicology, operating as Precision Diagnostics, agreed to pay $27 million to resolve allegations it submitted false claims for medically unnecessary urine drug tests and provided free items to physicians who referr…